𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid

✍ Scribed by Paul Angulo; Keith D. Lindor; Terry M. Therneau; Roberta A. Jorgensen; Michael Malinchoc; Patrick S. Kamath; E. Rolland Dickson


Book ID
111236163
Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
720 KB
Volume
19
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Cholesterol-lowering effect of ursodeoxy
✍ RenΓ©e E. Poupon; Khadija Ouguerram; Yves ChrΓ©tien; Claudine Verneau; Eveline Esc πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 591 KB

We have previously shown in a 2-yr controlled trial that hypercholesterolemia, frequent in primary biliary cirrhosis, is lowered by ursodeoxycholic acid (13 to 15 mg daily). To further investigate this effect, we analyzed the influence of long-term ursodeoxycholic acid administration on serum lipids